PULM Week 3 Flashcards

1
Q

what are the 4 stages of bacterial lobar pneumonia

A
  1. Congestion–> intracellular alveolar fluid, few neutrophils, often numerous bacteria
  2. Red Hepatization–> “like liver;” massive intra-alveolar neutrophils with RBCs and fibrin
  3. Grey hepatization–> macrophages replace neutrophils, and ingest debris
  4. Resolution–> but may have complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is broncho-pneumonia?

A

PATCHY, infective consolidation of the lung in predominantly LOBAR distribution

common especially in hospitalized patients and as a terminal event complicating systemic illness

usually BILATERAL

pre-existing infective bronchitis spreads to cause bronchiolitis and extends to involve adjacent lung parenchyma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is interstitial pneumonia?

A

infectious causes = viruses, rickettsia, chlamydia, mycoplasm, PCP

thickened alveolar walls are heavily infiltrated with mononuclear leukocytes in contrast to intra-alveolar PMN exudate of bacterial pneumonia

large spectrum of presentations–> extreme is ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are some complications that can arise due to pneumonia

A
  1. bacterial dissemination–> bacteremia resulting in meningitis, endocarditis, systemic pyogenic abscesses
  2. lung abscess formation–> pulmonary parenchymal destruction and suppuration (classically associated with S. aureus/anaerobes)
  3. empyema–> extension of inflammation to pleural cavity
  4. endocarditis
  5. death

**clinical picture is dramatically altered by administration of appropriate antibiotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pathogenesis of bacterial pneumonia

A
  1. pyogenic bacterium–> acute inflammation–> intra-alveolar pneumonia (LOBAR/broncho)
  2. viral–> infect type I pneumocytes–> alveolar injury–> INTERSTITIAL pneumonia
  3. TB/fungal–> GRANULOMATOUS inflammation (caseous or necrotizing)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is lobar pneumonia

A

characterized by area of UNIFORM consolidation of part of a lobe or the entire lobe

commonest type of CAP

majority are due to s. pneumo

lobar distribution is a function of the virulence of the bacterial organism and the vulnerability of the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is ARDS?

A

“acute respiratory distress syndrome”

clinical and pathological end result of severe, acute, alveolar injury–> severe diffuse damage to alveolar capillary wall

rapid onset of severe life threatening respiratory insufficiency–> may progress to extra-pulmonary multisystem organ failure

diffuse alveolar damage is the pathological abnormality that results in clinical ARDS

initial injury can be to capillary endothelium or alveolus but eventually both are affected–> final common pathway leads to predictable histological pathway associated with respiratory failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

etiology of ARDS

A

complication of many diverse conditions, including direct lung injury or a complication of systemic disorders

direct lung injury that can leads to ARDS–> diffuse pulmonary infection (i.e virus, pneumonia, SARS), inhaled irritant or gastric aspiration

systemic injuries that lead to ARDS can include septic shock, shock associated with trauma (i.e burns, pancreatitis, narcotic overdose), and near drowning

150 000 cases in the US/year

50% mortality–> often related to severe underlying pathology–> most survivors recover fully but some may have disability due to scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the name of the model used to describe the pathogenesis of ARDS

A

gram negative sepsis model

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what are the two stages in the pathogenesis of ARDS

A

exudative and healing/organizing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe the pathogenesis of ARDS

A

type I pneumocyte damage and endothelial cell damage–> inflammation–> fibroblast proliferation–> collagen deposition

this all leads to type II pneumocyte proliferation and interstitial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the exudative phase of ARDS pathogenesis

A
  1. ENDOTOXIN induces release of TNF alpha from monocytes and alveolar macrophages
  2. this causes upregulation of ADHESION molecules and release of cytokines from endothelial cells
  3. this causes activation of the ALTERNATE COMPLEMENT pathways to generate C5a which upregulates adhesion molecules on neutrophils
  4. adhesion molecule upregulation results in “sticking” of neutrophils to endothelium and sequestration of neutrophils in lung capillaries
  5. sequestered neutrophils–> activated neutrophils–> release oxygen free radicals, proteases, leukotriene, prostaglandins, all of which damage the endothelium and increase permeability and trigger coagulation
  6. this results in NECROSIS of endo and epithelial cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the path of activated neutrophils to necrosis of tissue in ARDS?

A

diffuse alveolar damage–> decreased lung surfactant concentration–> alveolar collapse

formation of the HYALINE MEMBRANE (pink on histo section)

“point of no return cascade”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the organizing/healing phase of ARDS pathogenesis

A

type II pneumocyte proliferation and intersitial fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ARDS pathological microscopic findings

A

early exudative phase characterized by interstitial and alveolar edema, cell necrosis and hyaline membrane formation

organizing healing phase characterized by alveoli lined by regenerating type II pneumocytes with intra-alveolar and interstitial fibrous tissue formation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ARDS pathological macroscopic findings

A

lungs are HEAVY and FIRM (may have superimposed pneumonia on top of ARDS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what cells secrete surfactant to prevent alveolar collapse

A

type II pneumocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what is the importance of elastin in the airways?

A

ubiquitous in the lung–> found in close association with collagen and proteoglycans

elastin and collagen fibers from alveoli, bronchi, interlobar septae and visceral pleura all have connections with fibers of the pulmonary arteries and therefore there is a continuum of fibers throughout the lung such that any force exerted on the parenchyma is distributed throughout the whole organ

elastin fibers also provide sufficient elasticity to allow lungs to return to original volume during expiration (compliance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

function of alveolar macrophages

A

dust cells

lung is rich with dust cells that pass freely from circulation through interstitial space and through the alveolar epithelium to lie on the alveolar surface

active in combatting infection and scavenging foregin bodies

have primary and secondary lysosomes in cytoplasm

irregular margins represent the many pseudopods and microvilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is tuberculosis

A

communicable chronic GRANULOMATOUS disease caused by mycobacterium tuberculosis

usually involves the lung but can affect any organ in the body

typically granulomas undergo CASEOUS NECROSIS

**6% of all deaths worldwide–> most common cause of death from a single infectious agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how does infection differ from disease

A

infection implies SEEDING of a focus with organisms which may or may not cause clinically significant tissue damage or disease

reservoir of the organism is found in humans with infection or disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how is TB spread

A

inhalation of airborne organisms in aerosols from infected persons or by exposure to aerosolized contaminated secretions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

pathogenesis of TB

A

cell mediated immunity confers resistance to the organism resulting in development of tissue hypersensitivity to tubercular antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

pathological features of TB

A

CASEATING GRANULOMAS and TISSUE CAVITATION

result of destructive tissue hypersensitivity that constitutes the host immune response

immune response comes at the cost of hypersensitivity and accompanying tissue damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

describe primary TB

A

develops in previously unexposed person–> source is exogenous (i.e inhaled bacilli implanted in distal air spaces of lower part of upper lobe or upper part of lower lobe, close to pleura)

as sensitization develops, a GHON FOCUS forms, and necrosis develops–> tubercle bacilli, either free or within macrophages, will drain to regional lymph nodes and also caseate–> once regional lymph nodes are involved the complex is called a GHON COMPLEX–> hematological and lymphatic spread to the body (first few weeks… seeding but no infection)

in 95% of cases, cell mediated immunity controls the infection

Ghon complex undergoes progressive FIBROSIS followed by CALCIFICATION–> foci of scarring may harbour viable bacilli for years–> prone to reactivation if immune compromised

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

what is progressive primary TB

A

uncommon
continues on from initial TB
occurs in immunecompromised states (AIDS, malnourishment, elderly, Inuit)
may result in miliary TB or TB meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

what is the Ghon focus

A

in primary TB, as sensitization develops, an area of grey/white inflammation consolidation emerges–> this is the Ghon focus

necrosis–> tubercle bacilli drain to regional lymph nodes and caseate

28
Q

what is the Ghon complex

A

after the tubercle bacilli drain to the regional lymph nodes and caseate, the Ghon complex forms, which is the combination of parenchymal lesion and nodal involvement

29
Q

what part of the TB mycobacteria is recognized by the macrophage

A

mannose-capped glycolipid on its membrane (recognized by the macrophages’ mannose receptor)

30
Q

how does TB manage to replicate within macrophages?

A

through endosomal manipulation–> maturation arrest, lack of acid pH, ineffective phagolysosomal formation

31
Q

describe secondary TB

A

pattern of disease that arises in PREVIOUSLY infected host

arises from reactivation of dormant primary lesions, usually many decades later (however, may also result from exogenous reinfection)

cavitation occurs readily in secondary form–> dissemination along airways–> initial lesion is usually less than 2cm; variable amount of central caseation and peripheral fibrosis; favorable cases undergo progressive fibrous encapsulation (leaving only fibro-calcific scar)

localized apical secondary pulmonary TB may heal with fibrosis spontaneously or after therapy

32
Q

where does secondary TB tend to localize?

A

apex of one or both upper lobes

33
Q

what is the source of infectivity from secondary TB

A

erosion of an airway

34
Q

what are some complications of secondary pulmonary TB

A
  1. progressive pulmonary TB
  2. erosion into bronchi with cavitation
  3. blood vessel erosion leading to hemoptysis
  4. miliary pulmonary disease
  5. pleural effusion/TB empyema
  6. endobrachial, endotracheal, laryngeal TB
  7. lymphadenopathy
  8. TB meningitis
  9. death
35
Q

what are the most common strains of non-TB mycobacteria in an immunocompromised host

A

MAC
M. kansasii
M. abscessus

can present clinically as upper lobe cavitary disease, mimicking TB
risk factors = COPD, CF, pneumoconiosis
hepatosplenomegaly, lymphadenopathy, GI symptoms are common

36
Q

what is MAC

A

mycobacterium avium complex

presents with disseminated disease with systemic symptoms (fever, night sweats, weight loss)

tend to occur late in disease (i.e in HIV with CD4 count below 100)

tissue exam does NOT reveal granulomas

instead, there is proliferation of FOAMY MACROPHAGES stuff with ATYPICAL mycobacteria

37
Q

what is MDR-TB

A

resistance of mycobacterium to 2 or more primary drugs used for treatment

50 mil people are infected with MDR-TB

38
Q

etiology of pulmonary fungal infection in immunocompetent host

A
  1. Blastomyces dermatiditis
  2. Histoplasma capsulatum
  3. Coccidioides immitis
  4. Cryptococcus neoformans
  5. Cryptococcus gattii

organisms manifest as fungal spores in tissue

39
Q

pathology of pulmonary fungal infection in immunocompetent host

A

pathological and clinical/radiology aspects similar to TB

GRANULOMATOUS inflammation with NECROSIS

acute primary pulmonary infection

chronic (including cavitary) infection

disseminated miliary disease

solitary pulmonary nodule–> resembling bronchogenic carcinoma radiologically

peri-hilar mass/lymphadenopathy resembling bronchogenic carcinoma radiologically

40
Q

how do you differentiate TB from fungal infection?

A

requires ID of fungal organisms in tissue or microbial culture

41
Q

etiology of pulmonary fungal infection in immunocompromised host

A
  1. aspergillus
  2. candida
  3. mucor mycoses

*organisms manifest as FUNGAL HYPHAE in tissues

42
Q

pathology of pulmonary fungal infection in immunocompromised hosts

A

necrotizing pneumonia

propensity for blood vessel invasion (angioinvasion)–> consequent tissue infarction

systemic dissemination (especially to brain)

43
Q

what is sarcoidosis

A

disease of UNKNOWN etiology characterized by NON-CASEATING, NON-NECROTIZING granulomas
(*note that mycobacteria and fungal infections do sometimes produce non-caseating, non-necrotizing granulomas)

sarcoidosis is a major ddx of infectious granulomatous inflammation

diagnosis of EXCLUSION

44
Q

what are some microscopic histological features of idiopathic pulmonary fibrosis (IPF)

A

PATCHY pattern of interstitial inflammation and fibrosis mixed with normal parenchyma

tends to be worse in PERIPHERY of lobule

scattered FIBROBLAST FOCI–> small tufts of granulation tissue applied to alveolar walls = hallmark of UIP

interstitial inflammation/airspace macrophages = minimal except in HONEYCOMBED foci

honeycombed areas are present by the time of biopsy (temporal and morphogenic heterogeneity)

45
Q

describe the morphogenesis of the changes seen histologically in IPF

A

a reparative pattern of proliferating fibroblasts often accompanied by capillary channels and chronic inflammatory cells

focal epithelial injury results in local fibrin deposition and outgrowth of fibroblasts from the interstitium to organize the fibrin (fibroblast foci) into granulation tissue

honeycombing is evidence of reorganization–> NO LONGER NORMAL TISSUE
–> fibrinolytic mechanisms are impaired in UIP

overproduction of PLASMINOGEN ACTIVATOR INHIBITOR leads to lacks of plasminogen and persisting fibrin

the epithelium grows over to incorporate the new granulation tissue into the interstitium (beginning of healing)

granulation tissue foci/fibroblast foci eventually become interstitial fibrous tissue

ALVEOLAR COLLAPSE with organization and eventual fibrosis leads to loss of alveoli–> both processes end as OLD, DENSE, scar tissue with reorganization of the parenchyma

normal granulation tissue is very sensitive to steroids but UIP is not sensitive

46
Q

define interstitial lung disease

A

the diffuse parenchymal diseases–> affects the parenchyma distal to the small airways

a large group of disorders, most of which cause progressive scarring of lung tissue

characterized by “too much” of something in the interstitial space (fused basement membranes)

increased COLLAGEN and other MATRIX PROTEINS

increased chronic inflammatory cells

GRANULOMAS

scarring eventually impacts ability to breathe and get enough O2 into the blood

47
Q

what constitutes the parenchyma

A

pulmonary alveolar epithelium, capillary endothelium, spaces between these structures, tissues within the septa, lymphatics of the lung and in the peri-vascular and peri-lymphatic areas

48
Q

list common interstitial lung diseases

A
  1. usual interstitial pneumonia
  2. sarcoidosis
  3. hypersensitivity pneumonitis
  4. pneumoconiosis (i.e asbestosis)
49
Q

clinical presentation of diffuse interstitial lung disease

A
  1. SOB (usually presenting complaint)
  2. dry cough
  3. systemic symptoms in some cases (fever, weight loss)
  4. clubbing (with severe disease)
  5. VELRO RALES heard on INSPIRATION
  6. most forms have interstitial markings on CXR
  7. RESTRICTIVE pulmonary function abnormalities
50
Q

what causes usual interstitial pneumonia (UIP)

A

aka idiopathic pulmonary fibrosis/IPF

most are idiopathic–> associated with collagen vascular disease, drug induced, familial, pneumoconiosis

collagen vascular diseases include scleroderma, rheumatoid arthritis, SLE

drugs include chemo agents, nitrofurantoin, amiodarone

51
Q

clinical features of UIP

A

disease of middle age and elderly

presents with insidious onset of SOB (long onset)

velcro rales on inspiration

clubbing in 50%

ANA, RF, cryoglobulins may be elevated even in those without collagen vascular disease

restrictive functional abnormalities

52
Q

UIP radiographic features

A

plain chest film shows RETICULONODULAR (interstitial) markers–> most severe in the lower zones

HONEYCOMBING seen on plain films in advanced disease

HRCT shows subpleural reticular pattern with predominantly subpleural honeycombing

53
Q

gross features of UIP

A

predominantly lower zone fibrosis and honeycombing

process is worse in the periphery of the lung

process is worse in the periphery of the nodule

54
Q

pathogenesis of UIP

A
  1. triggering injury–> exposure to environmental agents (cigarettes, wood, metal dust), viral infection (Hep C, epstein barr)
  2. immunological factors–> Th1/Th2 IMBALANCE in UIP
    - common to have autoantibodies that react with alveolar epithelium
    - upregulation of Th2–> production of IL-4/IL-5–> stimulation of fibroblast proliferation
    - absence of IFN gamma, which is an inhibitor of collagen synthesis
  3. cytokine factors–> increased levels of profibrotic cytokines found in macrophages and epithelial cells (i.e TGFbeta, TGFalpha, PDGF, IGF, endothelin-1)
  4. fibroblast anomalies–> persisting fibroblast abnormalities explain the progressive nature of the disease–> i.e increased MOTILITY, increased RATE of proliferation, anchorage independent of growth, resistance to apoptosis, hypermethylation of promoter Thgamma-1 (gene switched off)
  5. epithelial abnormalities
55
Q

what are the roles of Th1 and Th2 in UIP pathogenesis

A

messed up Th1/Th2 balance

Th1 is cell mediated immunity–> INGgamma, IL2, IL12, IL18–> tissue RESTORATION

Th2 is antibody mediated immunity–> IL4, IL5, IL10, IL13 plus fibroblast activation and matrix deposition leading to fibrosis

56
Q

complications from UIP

A
  1. acute exacerbation (UIP with superimposed ARDS)
  2. carcinoma of the lung (10X risk)
  3. pulmonary HTN/cor pulmonale
  4. respiratory failure
57
Q

UIP prognosis

A

invariable progressive with mean survival 3 years

not responsive to steroids

not responsive to cyclophosphamide

only effective treatment is LUNG TRANSPLANT for young patients

58
Q

what causes restrictive lung diseases

A

interstitial lung disease

densely fibrotic pleura

chest wall muscle weakness

cheat wall deformity or massive obesity

59
Q

findings in restrictive lung disease

A

small volumes on spirometry (FVC, FEV1)

small volumes in body box (TLC)

flow preserved or increased FEV1/FVC

compliance decreased

typically diffusing capacity is decreased

60
Q

what are some environmental agents that must be ID-ed in a patient presenting with interstitial lung disease

A
  1. (inciting agent)–> Avian Ags–> i.e keepers of parakeets/chickens/turkeys/budgies/pigeons
  2. asbestos–> i.e mining, insulation
  3. fungal spores–> i.e humidifiers, mouldy hay (farmers), sugar cane, cork, maple, oak, tobacco
  4. silica–> i.e mining, sand blasting, ceramics
    * ask if occupation is in an area of dust or fumes and if it is well ventilated
61
Q

what is pneumonia

A

generic term that refers to inflammation of the pulmonary parenchyma

62
Q

list 3 classifications of pneumonia

A
  1. lobar pneumonia
  2. bronchopneumonia
  3. interstitial pneumonia
63
Q

list 4 clinical designations of pneumonia

A
  1. CAP
  2. pneumonia in immunocompromised
  3. hospital acquired
  4. aspiration pneumonia
64
Q

etiology of bacterial pneumonia

A

bacterial, viral, fungal or other (pneumocystis, rickettsia, chamydial, mycoplasma)

  1. bacterial–> S. pneumo, S. aureus, H. influenziae, Klebsiella, Pseudomonas, Leigionella, Bacteroides, fusobacterium
  2. viral (INTERSTITIAL PNEUMONIA)–> influenza, CMV
  3. fungal–> histoplasma, coccidioides, aspergillus
  4. PCP
65
Q

what conditions can predispose you to bacterial pneumonia

A
  1. suppression of cough reflex (anaesthesias, coma, neuromuscular disorder)
  2. impaired systemic immunity (AIDS, leukemia, cytotoxic chemo)
  3. impaired mucociliary apparatus (cigarette smoke, underlying viral infection, immotile cilia syndrome)
  4. impaired alveolar macrophage function (cigarette smoke, alcohol)
  5. pulmonary edema (cardiac failure)
  6. general debility (alcoholism, post-operative, malnourishment)